Home > Boards > Free Zone > Health and Sciences > Biotech Values

If the progression assessments for the two metrics

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
DewDiligence Member Profile
Member Level 
Followed By 477
Posts 80,160
Boards Moderated 22
Alias Born 09/05/02
160x600 placeholder
Apple Reports Strong Iphone Sales
Apple reported its fiscal third quarter profit rose 12.3% to $7.75 billion as iPhones sales rose 12.7% to 35.2 million. Per share earnings rose to $1.28, adjusted for the company's recent 7-for-1 stock split.
More Top Equities Stories Of The Day
European Stocks Slip; Shire Leads FTSE Gains
Dow Rises to Record Close
Apple, Microsoft On The Rise With Earnings On Tap
U.S. Hot Stocks: Hot Stocks to Watch
GE Seeks to Raise $3.1 Billion in Synchrony Financial IPO -- 4th Update
Netflix Earnings More Than Double
Credit Suisse to Exit Commodities Trading
Taiwan Export Orders Point to Stronger Global Demand
DewDiligence Member Level  Thursday, 05/24/12 02:22:04 PM
Re: jq1234 post# 142539
Post # of 180615 
If the progression assessments for the two metrics are made on the same schedule for every patient, it shouldn’t be possible for PFS to be greater than TTP. A death in between progression assessments ought not to cause a patient to be deleted from the TTP dataset, but rather for TTP to be censored at the time of death.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist